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ABSTRACT
Objectives To describe trends in the numbers of Down’s
syndrome live births and antenatal diagnoses in England
and Wales from 1989 to 2008.
Design and setting The National Down Syndrome
Cytogenetic Register holds details of 26488 antenatal
andpostnataldiagnosesofDown’ssyndromemadebyall
cytogenetic laboratories in England and Wales since
1989.
Interventions Antenatal screening, diagnosis, and
subsequent termination of Down’s syndrome
pregnancies.
Main outcome measures The number of live births with
Down’s syndrome.
Results Despite the number of births in 1989/90 being
similar to that in 2007/8, antenatal and postnatal
diagnoses of Down’s syndrome increased by 71% (from
1075 in 1989/90 to 1843 in 2007/8). However, numbers
of live births with Down’s syndrome fell by 1% (752 to
743; 1.10 to 1.08 per 1000 births) because of antenatal
screening and subsequent terminations. In the absence
of such screening, numbers of live births with Down’s
syndrome would have increased by 48% (from 959 to
1422),sincecouplesarestartingfamiliesatan olderage.
Among mothers aged 37 years and older, a consistent
70%ofaffectedpregnancieswerediagnosedantenatally.
In younger mothers, the proportions of pregnancies
diagnosed antenatally increased from 3% to 43% owing
to improvements in the availability and sensitivity of
screening tests.
ConclusionsSince1989,expansionofandimprovements
in antenatal screening have offset an increase in Down’s
syndrome resulting from rising maternal age. The
proportion of antenatal diagnoses has increased most
strikinglyinyoungerwomen,whereasthatinolderwomen
has stayed relatively constant. This trend suggests that,
even with future improvements in screening, a large
number of births with Down’s syndrome are still likely,
and that monitoring of the numbers of babies born with
Down’s syndrome is essential to ensure adequate
provision for their needs.
INTRODUCTION
Between 1989 and 2008 two changes occurred that
influenced the numbers of diagnosed Down’s syn-
drome pregnancies, despite no change in the overall
number of births in England and Wales. First was the
considerableincreaseinmaternalage,whichisamajor
knownriskfactorforDown’ssyndrome.
12Secondwas
the increase in antenatal diagnoses of Down’s syn-
drome, which included non-viable fetuses who would
not have survived to term and therefore remained
undiagnosed.
3
In the early years of the period from 1989 to 2008,
the major indication for invasive antenatal diagnosis
was a maternal age of 37 years or older. Since the
mid-1990s,maternalserumtestingand,later,measure-
ment of fetal nuchal translucency, were successful
screening tests, and antenatal screening has achieved
higherratesofcorrectpredictionsandhighercoverage
year on year. In 2001, the UK National Screening
Committee advised that all pregnant mothers should
be offered one of the available screening tests for
Down’s syndrome, and their recommendations for
2007–10 are that these tests should have a positive
rate of less than 3% and a detection rate of more than
75%.
4
This report describes the effects of the changes in
maternal age and advances in screening on the inci-
dence of live births with Down’s syndrome, and on
the number of antenatal diagnoses between 1989 and
2008 in England and Wales.
METHODS
Data collected
The National Down Syndrome Cytogenetic Register
1
was set up on January 1 1989, and holds anonymous
data from all clinical cytogenetic laboratories in Eng-
land and Wales for more than 26000 cases of Down’s
syndromediagnosedantenatalor postnatally.
5 Almost
every baby with clinical features suggesting Down’s
syndrome, as well as any antenatal diagnostic sample
from a pregnancy suspected to have Down’s syn-
drome, receives a cytogenetic examination, since the
definitive test for the syndrome is detection of an extra
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laboratoriesinEnglandandWalesareaskedtosubmit
to the register a completed form for each such diagno-
sis and its variants. The form contains details of the
date, place of, and indications for referral, maternal
age, and family history. Most laboratories send a
copy of this form to the referring physician for confir-
mation and completion.
Thedatahavebeencomparedwiththosefromother
congenital anomaly registers and those of the UK
Office for National Statistics. These comparisons
haveshownthatsinceitsinceptiontheregisterhascap-
tured data for an estimated 93% of all diagnosed births
and pregnancy terminations to residents of England
and Wales.
6 All data are presented by financial year
(from April 1 1989 to March 31 2008).
Missing maternal ages
Five per cent of records had missing maternal age, of
whichmorethan95%werepostnataldiagnoses.Every
case was assigned a set of probabilities of the mother
being aged from 15 to 50 years, calculated from the
distribution of single years of known maternal ages
registered in the same year, matched for antenatal or
postnatal diagnoses. The probabilities were then used
inanycalculationsinvolvingmaternalage.Allwomen
younger than 37 years were classified as younger
women and women aged 37 and older as older
women for presentation purposes. Age 37 years was
chosen as the threshold because at the start of the reg-
ister, age was used as the initial screening test with
many women of this age or older being offered an
antenatal diagnostic test before other antenatal screen-
ing tests became available.
Adjustment for natural fetal losses
The data included pregnancies that were diagnosed
antenatally and subsequently terminated. Many of
these pregnancies would not have survived to term
and would therefore previously never have been diag-
nosed (miscarried fetuses are generally not karyo-
typed). For a comparison of the annual numbers of
live births that would have occurred in the absence of
antenatal diagnosis and subsequent terminations,
adjustment must be made for the risk of a natural mis-
carriage. To do this, the number of terminations is
weightedbytheestimatedriskofmiscarriage,allowing
for the fall in risk with increasing gestational maturity
and the increase in risk with increasing maternal age.
7
Forexample,atamaternalageof35years,only57%of
Down’s syndrome fetuses diagnosed at 13 weeks’
gestation result in a live birth (the others miscarry or
are stillborn), so that terminations that occurred at
around 13 weeks’ gestation to such mothers are
weightedby0.57toestimatethenumbersoflivebirths
that would have occurred at term. This means, for
example, that the occurrence of two terminations at
13 weeks to 35 year old mothers is equivalent to
around one birth occurring.
Missing outcomes
Theoutcomeofeachpregnancydiagnosedantenatally
is followed-up, but ascertainment has been slow for
certain laboratories in recent years. This is partly
becauseoftheincreasedusedofprivatediagnostictest-
ing, so that the place of testing is not the same as the
placeofpregnancyoutcome.However,thereasonsfor
missing outcomes are unrelated to the actual outcome
and to maternal and gestational age in cases subse-
quently traced. To examine trends in the proportion
of women deciding to continue with the pregnancy
on receiving a antenatal diagnosis of Down’s syn-
drome, we excluded all cases with missing outcomes.
To check the validity of doing so, we also examined
every year’s outcome data separately, and data from
a specific laboratory were included only if outcomes
were available for more than 95% of diagnoses. With
this smaller dataset, the estimated proportion of
women deciding to terminate the pregnancy was the
sameasthatderivedfromthefirstmethodofexcluding
all cases with missing outcomes, the findings of which
are presented in the results.
RESULTS
Trends in diagnoses and live births
The table shows the increase in diagnoses of Down’s
syndromebetween1989and2008,from1075in1989/
90 to 1843 in 2007/8. These values include live births
and stillbirths diagnosed postnatally, and outcomes
after antenatal diagnoses (terminations, fetal losses,
and a small number in which the pregnancy was con-
tinued to term).The number of affected live births was
752 in 1989/90 and 743 in 2007/8 (a 1% decrease).
Around 92% of women who received an antenatal
diagnosis of Down’s syndrome decided to terminate
the pregnancy, and this proportion was constant
throughout the period covered by the register.
Figure 1 compares the total number of Down’s syn-
drome diagnoses (top line) with the estimated number
of Down’s syndrome live births that would have
occurred in the absence of antenatal diagnoses and
selectivetermination(middleline).Thetwolinesdiffer
becausesomeofthesepregnancieswouldhavemiscar-
ried naturally and not resulted in a live birth. The bot-
tom line gives the estimated number of Down’s
syndrome live births that did occur in the presence of
antenataldiagnosesandselectivetermination.Thedif-
ference between the bottom two lines is attributable to
antenatal screening and subsequent terminations, the
effects of which have clearly increased over time.
Trends in maternal age
The middle line in figure 1 is the number of live births
expected in the absence of screening and subsequent
terminations; the rise (from 959 in 1989/90 to 1422 in
2007/8) is therefore due to a true increase in the inci-
denceofDown’ssyndrome,whichcanbeattributedto
the increase in maternal age.
Figure 2a shows the changes in maternal age for all
births in England and Wales, and figure 2b shows the
consequent effect on Down’s syndrome pregnancies.
8
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alargeeffectonthenumberofDown’ssyndromepreg-
nancies because the risk of an affected pregnancy is
greatly increased for older mothers; the risk for a
40 year-old mother is 16 times that for a 25 year-old
mother.
Trends in antenatal screening
Because maternal age is such a powerful predictor it is
the most important element of estimation of risk in all
screening programmes. In the early years of the
register, maternal age was the only method of screen-
ing, and women older than 36 years were offered an
amniocentesis. For women younger than 37 years old
(fig 3a) few screening tests were available in 1989 and
the early 1990s. Antenatal diagnosis was generally
doneinthesewomenforotherreasons,suchasafamily
history of Down’s syndrome, or findings of so-called
soft markers at fetal ultrasound examinations, which
became more common in the early 1990s. Even
when validated screening tests became available, they
had lower detection rates in younger than in older
women.Thattheproportionofpregnanciesdiagnosed
antenatally in younger women, which was 3% at the
start of the register, began to increase rapidly after
about 1993 to around 43% in 2007/8 is therefore
unsurprising. Figure 3b shows that the proportion of
pregnanciestowomenof37yearsandolderdiagnosed
antenatally remained at around 70%, with the propor-
tion diagnosed antenatally due to age alone being
replaced with diagnoses due to other types of screen-
ing.
An important consequence of these changes is that
the mean age of mothers of live born children with
Down’s syndrome has risen over time, from 30.
6years(sd=6.1years)in1989/90to34.4years(sd=6.
8 years) in 2007/8, while the age of mothers of antena-
tally diagnosed cases has fallen.
DISCUSSION
We have shown in this paper that the two factors that
influence the numbers of live births with Down’s
Down’s syndrome diagnoses in England and Wales from 1989/90 to 2007/8 according to year of diagnosis and outcome
Financial
year of
diagnosis
Diagnoses Outcomes of antenatal diagnoses† (%)
All Antenatal
Live births
Unknown
outcomes Terminations
Miscarriages /
stillbirths Live births Reported Estimated*
1989-90 1075 329 752 752 6 93.2 2.5 4.3
1990-1 1106 386 741 742 14 88.4 4.3 7.3
1991-2 1168 445 744 745 11 88.5 4.4 7.1
1992-3 1128 514 625 626 18 92.1 3.2 4.6
1993-4 1218 595 645 646 11 93.2 2.1 4.8
1994-5 1234 622 628 629 24 91.6 3.2 5.2
1995-6 1214 655 582 583 19 91.2 2.8 6.0
1996-7 1352 758 607 608 17 92.7 2.8 4.5
1997-8 1395 733 680 682 32 91.7 2.6 5.7
1998-9 1266 684 610 612 30 91.6 2.0 6.4
1999-00 1348 765 608 610 38 91.9 1.9 6.2
2000-1 1387 822 591 595 70 92.4 1.3 6.3
2001-2 1394 833 588 594 102 91.1 2.7 6.2
2002-3 1481 908 603 609 106 92.4 2.1 5.5
2003-4 1476 877 638 643 79 89.6 2.8 7.6
2004-5 1735 1039 716 725 143 89.8 3.8 6.4
2005-6 1843 1108 746 757 175 91.6 2.8 5.6
2006-7 1825 1108 729 740 176 91.3 3.2 5.5
2007-8 1843 1112 730 743 214 92.8 2.5 4.8
Total 26488 14293 12563 12640 1285 91.5 2.7 5.8
*Estimated live births includes 6% of unknown outcomes.
†Calculated as a proportion of all known outcomes.
All diagnoses (71% increase)
Live births in the absence of antenatal screening and
subsequent terminations (48% increase)
Live births in the presence of antenatal screening and
subsequent terminations (1% increase)
Financial year of diagnosis
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Fig 1 | Down’s syndrome diagnoses and live births according to
year of diagnosis and presence or absence of antenatal
screening and subsequent terminations
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due to the distribution of maternal age, and the num-
bers of pregnancies that are detected antenatally and
subsequentlyterminated—havechangedconsiderably
over the life of the register. Increases in maternal age
would have caused a 48% increase in births with
Down’s syndrome in the absence of terminations
between 1989-91 and 2005-7. However, terminations
of Down’s syndrome pregnancies due to an increase
and improvements in antenatal screening have caused
the number of live births with Down’s syndrome to
remain constant.
In older women, a constant proportion of around
70% of diagnoses of Down’s syndrome are antenatal.
In the earlyyears ofthe register,thiswasbecause most
accepted a diagnostic test because of their advanced
maternal age alone, but it is now accounted for by
most accepting a diagnostic test due to having had a
different screening test.
In younger women, the implementation of more
recent methods of screening has had a greater effect,
because reasons to offer them diagnostic tests were
rare before the availability of these methods, and the
earliestscreeningtestswerenotverysensitive.By2007
all womenshouldhavebeen offeredscreeningand the
testsavailableweremuchimproved,withhigherdetec-
tion rates and fewer false positives. Data from the reg-
istershowthattheproportionofantenataldiagnosesin
younger women has increased rapidly, but the data
shown in figure 3 suggest that this will also plateau at
around 70%. In 1992, a prediction was made based on
available evidence, that no more than 60% of all
women would take up antenatal screening.
9 In view
oftheapparentplateauinuptakeofantenataldiagnosis
and the increasing maternal age, an increase in the
number of affected births was predicted. However
this prediction underestimated the future power and
effectiveness of new screening techniques. The annual
number of Down’s syndrome live births has remained
fairly steady as the number of pregnancies terminated
balance those resulting from the age-related increase.
Thisplateauwillnotnecessarilyremainifmaternalage
continues to increase and the proportion of parents
accepting screening and opting for a termination
remains the same or decreases. However, the propor-
tion of women who decide to terminate the pregnancy
when they receive an antenatal diagnosis of Down’s
syndrome has remained constant at 92% throughout
the life of the register.
Thefindingsalsoshowthatparentscurrentlyexpect-
ing a baby with Down’s syndrome tend to be older
than those in previous cohorts, a fact that needs to be
considered when planning long term care for those
affected.Moreover,suchcarewillneedtobeextended
as life expectancy is probably rising faster in indivi-
duals with Down’s syndrome than in others. These
concerns might be mitigated somewhat by the much
improved educational attainment and social accep-
tance of people with Down’s syndrome.
The National Down Syndrome Cytogenetic Regis-
ter is a unique resource that has ascertained over 93%
ofdiagnosesofDown’ssyndromeinallofEnglandand
Wales over 19 years. It has enabled the effects of
changes in screening policies to be accurately moni-
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Fig 3 | Reasons for Down’s syndrome diagnoses according to
year of diagnosis for women younger than 37 years and
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and Wales for 1989-91 compared with 2005-7
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drome in England and Wales is that collected by the
National Congenital Anomaly System, which is too
incomplete to monitor trends.
610Regional congenital
anomaly registers collect data that enable monitoring
of regional trends, but these registers cover only
around 55% of all births in England and 100% of all
births in Wales.
10 The main current weakness of the
National Down Syndrome Cytogenetic Register is
the necessity to estimate the number of live births,
because of largely administrative delays in receiving
data for some pregnancy outcomes after an antenatal
diagnosis. However, these delays are unrelated to the
outcome in cases that we have subsequently managed
to trace, and we are finding that with increased
resources cases are often traceable.
Other countries have reported similar trends in
Down’s syndrome diagnoses, screening, and subse-
quent live births, generally by merging their birth
registries with data from cytogenetic laboratories.
11-15
The National Down Syndrome Cytogenetic Register
covers a greater population (all of England and
Wales) and a longer period of changing diagnostic
technologies than do registers from other countries.
In conclusion, dramatic changes in demography
have been offset by improved medical technology
and have resulted in no substantial changes in the
birth prevalence of this quite disabling condition.
Despite these underlying changes, it is striking that
for women older than 36 years with a Down’s syn-
drome pregnancy, the proportion who have had an
antenatal diagnosis has remained constant at 70%,
and for all women with an antenatal diagnosis of
Down’ssyndrometheproportionwhodecidetotermi-
nate the pregnancy has remained constant at 92%.
These findings indicate that even with improved
screening tests, a considerable proportion of women
may still decide not to be screened, and a qualitative
study investigating why some women decide not to be
screened would be valuable. To ascertain whether the
decision is an informed one and, if not, to address the
lack of information, is important. Knowledge about
how much the risk of fetal loss after amniocentesis or
chorionic villus sampling influences the decision to
have a diagnostic test would help us to predict the
impact of the future introduction of non-invasive diag-
nostic tests. The lack of iatrogenic risk may result in a
higher uptake than current diagnostic tests, which
would reduce, or even abolish, invasive diagnostic
tests, and could substantially increase the numbers of
therapeutic abortions of affected fetuses at an earlier
gestational age.
16 These future changes need to be clo-
sely monitored to ensure that appropriate resources
are available both for the potentially increasing num-
bers of therapeutic abortions and also for the babies
who will still be born with Down’s syndrome.
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WHAT IS ALREADY KNOWN ON THIS TOPIC
Older mothers are at increased risk of having babies with Down’ss y n d r o m e .
Antenatal screening for Down’s syndrome is more available now than in the early 1990s.
WHAT THIS PAPER ADDS
Thenumber ofdiagnoses ofDown’s syndromehas increased by71% (from 1075 in1989/90
to 1843 in 2007/08), whereas that of live births decreased by 1% (755 to 743), owing to
antenatal screening and subsequent terminations.
In the absence of antenatal screening and subsequent terminations, the numbers of Down’s
syndromebirthswouldhaveincreasedby48%duetoparentschoosingtostartfamilieslater.
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